Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary Gastric Lymphoma.

Peter G Isaacson1

  • 1University College London Medical School, Department of Histopathology, London, England.

Pathology Oncology Research : POR
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Gastric MALT lymphoma pathogenesis begins with H. pylori infection, leading to localized lymphoid tissue growth. Eradicating H. pylori can treat early-stage lymphoma, before potential high-grade transformation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The aberrant intraepithelial T cells in refractory coeliac disease show epidermotropism.

Journal of clinical pathology·2014
Same author

Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups.

Histopathology·2013
Same author

An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.

PloS one·2012
Same author

A rare case of gastric MALT lymphoma resistant to multiple treatment regimens.

Journal of clinical pathology·2012
Same author

BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.

Haematologica·2011
Same author

Composite primary cutaneous peripheral T-cell lymphoma and Epstein-Barr virus-positive large B-cell lymphoma.

Leukemia & lymphoma·2011
Same journal

Multiple subcutaneous nodules as the primary presentation of angioimmunoblastic T-cell lymphoma: a case report and literature review.

Pathology oncology research : POR·2026
Same journal

<i>Connexin 43</i> enhances liver metastatic ability of GIST cells <i>in vivo</i>.

Pathology oncology research : POR·2026
Same journal

Proof-of-principle 4-marker spatial profiling reveals distinct, location-independent immune clusters in biliary tract cancers.

Pathology oncology research : POR·2026
Same journal

Genotyping of suspected partial hydatidiform moles - our experiences and future directions.

Pathology oncology research : POR·2026
Same journal

Prognostic impact of p53 and HER2 immunohistochemistry profiles in colorectal carcinoma.

Pathology oncology research : POR·2026
Same journal

Delayed diagnostic imaging but stable treatment initiation for kidney cancer during the COVID-19 pandemic: a Hungarian cohort study.

Pathology oncology research : POR·2026
See all related articles

Area of Science:

  • Gastroenterology
  • Oncology
  • Immunology

Background:

  • Mucosa-Associated Lymphoid Tissue (MALT) lymphoma originates from H. pylori infection.
  • Early-stage MALT lymphoma is antigen-dependent and localized.
  • Genetic changes, like trisomy 3, may confer a growth advantage.

Purpose of the Study:

  • To elucidate the pathogenesis of gastric MALT lymphoma.
  • To highlight the role of H. pylori in MALT lymphoma development and progression.
  • To identify therapeutic windows for early-stage gastric MALT lymphoma.

Main Methods:

  • Review of existing literature on gastric MALT lymphoma.
  • Analysis of the proposed pathogenetic pathway from H. pylori infection to lymphoma.
  • Discussion of genetic alterations and their potential role.

Related Experiment Videos

Main Results:

  • Gastric MALT lymphoma arises from H. pylori-induced MALT accumulation.
  • The lymphoma is initially T-cell dependent and antigen-driven.
  • H. pylori eradication is effective in early, localized stages.

Conclusions:

  • Early gastric MALT lymphoma is treatable via H. pylori eradication.
  • Further genetic alterations can lead to aggressive disease and transformation.
  • Understanding pathogenesis is key to effective therapeutic strategies.